Job Seekers, Welcome to LOA Careers
Search Filters
Use this area to filter your search results. Each filter option allows for multiple selections.
Search Results: 40 Jobs
Save Agent
Loading... Please wait.
Oliver Lab -- Emory University School of Medicine Logo
Oliver Lab -- Emory University School of Medicine

Atlanta, Georgia

POINT Biopharma Logo
POINT Biopharma


Point Biopharma Logo
Point Biopharma

Indianapolis, Indiana

Zucker School of Medicine at Hofstra/Northwell Logo
Zucker School of Medicine at Hofstra/Northwell

New York, New York

Ohio Wesleyan University Logo
Ohio Wesleyan University

Delaware, Ohio

Appalachian State University - Department of Chemistry and Fermentation Sciences

Boone, North Carolina

Baylor College of Medicine Logo
Baylor College of Medicine

Houston, Texas

Wake Forest University

Winston Salem, North Carolina

National Park Service

Twentynine palm, California

Cluster of Excellence on Plant Sciences CEPLAS Logo
Cluster of Excellence on Plant Sciences CEPLAS

Köln, Germany

University of Luxembourg

Kirchberg, Luxembourg

Electricities of NC Logo
Electricities of NC

Raleigh, North Carolina

Pennsylvania State University

University Park, Pennsylvania

USDA-Agricultural Research Service / ORISE

Albany, California

University of Pennsylvania

Philadelphia, Pennsylvania

Department of Biology, University of Saskatchewan

Saskatoon, Saskatchewan, Canada


Syracuse, New York

The University of Minnesota Logo
The University of Minnesota

Saint Paul, Minnesota

University of Georgia (UGA)

Athens, Georgia

Max Planck Institute for Heart and Lung Research Logo
Max Planck Institute for Heart and Lung Research

Bad Nauheim, Germany

Loading... Please wait.
Expand Show Other Jobs
Job Saved Save Job
Employer Logo
Postdoctoral Fellow
Oliver Lab -- Emory University School of Medicine
Email Print
Employer Logo
About Oliver Lab -- Emory University School of Medicine
Dr. Oliver has pursued studies of cystic fibrosis (CF) pathogenesis since 2009. She began her scientific career as a master’s student at Auburn University, where she characterized adaptive metabolic strategies by which Pseudomonas aeruginosa chronically establishes itself in the lungs of individuals with CF. After graduating with an M.S. in Microbiology, she worked one year as Lead Instructor for the “Genetics and Evolution” course at the University of Alabama in Huntsville. In 2012, Dr. Oliver enrolled in the Genetics graduate program at the University of Alabama at Birmingham to study CF disease mechanism. Her dissertation project utilized high-throughput yeast phenomics to identify novel genetic modifiers of the most common CF-causing variant (F508del-CFTR) and elucidated, for the first time, effects of ribosomal perturbation on CFTR synthesis, trafficking, and function. Dr. Oliver began postdoctoral training at Emory University in 2017 and continued to work towards a career in basic and translational science. Her studies concentrated on evaluating changes in translation kinetics – both in vitro and in vivo – following suppression of specific ribosomal proteins. In 2021, Dr. ...Oliver was promoted to Assistant Professor of Pediatrics at Emory. Her current research program employs interdisciplinary approaches in molecular genetics, RNA biology, biochemistry, cellular physiology, and functional genomics to investigate impact of translational speed, ribosome fidelity, and mRNA surveillance on protein synthesis in the context of CF. Particular emphasis is placed on premature termination codons (PTCs) and other rare defects that occur in the CFTR gene, specifically evaluating underlying mechanism(s) responsible for genotype-phenotype correlation, pharmacologic responsiveness, and heterogeneity of patient outcomes. Dr. Oliver’s scientific objectives also include better delineation of genetic factors that influence severity of refractory CFTR variants, including attention to mutations that occur in non-Caucasian people with the disease. Her overarching goals are to provide new insights relevant to CF clinical intervention and extend research findings to other pediatric conditions with similar etiology. Dr. Oliver presently serves on the national CF Foundation (CFF) Clinical Guidelines Steering Committee and CFF Guidelines Committee for CF Related Metabolic Disorder and CF Screen Positive Inconclusive Disorder, as well as the CF Newborn Screening Committee within the Georgia Department of Public Health.
Connections working at Oliver Lab -- Emory University School of Medicine
Loading. Please wait.